Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

Australia has banned life insurance companies from using genetic testing information to deny or restrict policies.

An uncommon congenital fourth branchial cleft cyst presents after exercise as a painless, mobile posterior neck mass, ...

Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security.

The Endocrine Society has concerns of possible delays in care and other problematic areas of The Lancet Commission’s proposed new obesity framework; a Commission author cites ‘conceptual confusions.’ ...

A systematic review and meta-analysis sheds light on the debated association between hormonal contraception and risk for idiopathic intracranial hypertension.

Higher levels of vitamin D in early midlife were associated with significantly lower levels of tau deposition 16 years later in adults without dementia.

In immunocompromised patients with acute hypoxemic respiratory failure, frailty and longer hospital-to-ICU time may raise 30-day mortality, whereas high-flow nasal oxygen is protective.

Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.

Tirzepatide produced notable weight loss in real-world settings, but patients with prior weight loss experienced smaller additional reductions than those without.

Healthcare systems face pressure to cut emissions while maintaining care quality, while clinicians report gaps in knowledge, training, and time to address climate-related risks.

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.